L-alanyl-L-glutamine dipeptide–supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study*

Pierre Déchelotte(Inserm), G Bleichner, Bernard Allaouchiche(Université Claude Bernard Lyon 1), M. Mazerolles(Centre Hospitalier Universitaire de Toulouse), D. Barn�oud, V. Merle, Luc Cynober(Sorbonne Paris Cité), Pierre Czernichow, B. Hecketsweiler, O. Mansoor, Moı̈se Coëffier(Inserm), G Colas, Michel Hasselmann, Jean Petit, Y.M. Guillou, D. Samba, R Cohendy(Centre Hospitalier Universitaire de Nîmes)
Critical Care Medicine
February 22, 2006
Cited by 329


Related Papers